News roundup 7 January 2019

iThera recalibrates series C
Having achieved an initial close of $8m in September, the Helmholtz spinout has now closed its series C round at $10.3m.
Iota jots down $15m series A
UC Berkeley spinout Iota Biosciences has obtained $15m in series A capital from investors including Astellas.
Boston Scientific picks up Millipede for $325m
Boston Scientific has exercised its option to wholly acquire Millipede, based on research at Michigan, having purchased a $90m stake in the mitral regurgitation treatment device maker last year.
Qwick recruits UAVC for $1.3m round
UAVC has returned to back UA-founded hospitality staffing platform Qwick after investing an undisclosed sum in November 2018.
PreOmics sheds light on $3.8m series A
HTGF, Think.Health Ventures and Business Angels have also supplied funding to Max Planck Institute for Biochemistry mass spectrometry spinout PreOmics.
Shimane ships in $1.9m for nanotech
The funding for Shimane’s Nanotechnology Project Center came from San-in Godo Bank through an industry-academia cooperation program.
Light Theto senses Tsinghua for series B round
THC Ventures has led a $14.5m round that will fund Light Theto’s R&D activities.
Itochu kicks off Promethera’s series D round
UCL spinout Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.